External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CTAD 2020

-
Coming soon
01:00 AM
Duration 15mins Virtual
The Amsterdam Instrumental Activities of Daily Living Questionnaire in prodromal vs. mild Alzheimer’s disease: Analysis of baseline data from the Tauriel study
Teng E, Manser P, Randolph C, Pickthorn K, Blendstrup M, Keeley M, Scheltens P, Sikkes SAM

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 15mins Virtual
Development of a disease progression model for Alzheimer’s Disease informed by multiple clinical trials and ADNI to predict longitudinal trajectory of CDR-SOB score
Jamalian S, Dolton M, Chanu P, Ramakrishnan V, Wildsmith K, Toth B, Manser P, Teng E, Jin J, Quartino A, Hsu JC

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:32 AM
Duration 30mins Virtual
Safety and efficacy of semorinemab in prodromal-to-mild Alzheimer’s disease: Preliminary analyses of the Phase 2 Tauriel study
Teng E, Manser P, Brunstein F, Wildsmith K, Dolton M, Pickthorn K, Sanabria-Bohorquez S, Blendstrup M, Keeley M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:00 AM
Duration 15mins Virtual
The Alzheimer’s Disease Event Inventory: Analysis of baseline data from the Tauriel study
Teng E, Manser P, Kerchner GA, Ward M, Pickthorn K, Blendstrup M, Lansdall C, Keeley M, McDougall F

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar